MAPT and Alzheimer disease: While the ATN framework involving Aβ and tau continues to be adopted as the pathogenic mechanism of AD [63], further downstream mechanisms involving the development of neurotoxicity in AD via disruption of Ca2+ homeostasis and mitochondrial dysfunction [64] were reported.